Intellia’s EVP and Chief Operating Officer, Andrew Schiermeier will be on a panel at @alliancerm’s Cell and Gene Meeting on the Mesa discussing #genomeediting and #celltherapy at 3 pm ET. #Mesa20 #CRISPR https://t.co/mCr7BsCJ97